1. Home
  2. MDGL vs TKR Comparison

MDGL vs TKR Comparison

Compare MDGL & TKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • TKR
  • Stock Information
  • Founded
  • MDGL 2011
  • TKR 1899
  • Country
  • MDGL United States
  • TKR United States
  • Employees
  • MDGL N/A
  • TKR N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • TKR Metal Fabrications
  • Sector
  • MDGL Health Care
  • TKR Industrials
  • Exchange
  • MDGL Nasdaq
  • TKR Nasdaq
  • Market Cap
  • MDGL 6.4B
  • TKR 5.4B
  • IPO Year
  • MDGL N/A
  • TKR N/A
  • Fundamental
  • Price
  • MDGL $340.14
  • TKR $76.71
  • Analyst Decision
  • MDGL Buy
  • TKR Buy
  • Analyst Count
  • MDGL 14
  • TKR 10
  • Target Price
  • MDGL $351.67
  • TKR $92.63
  • AVG Volume (30 Days)
  • MDGL 392.5K
  • TKR 491.6K
  • Earning Date
  • MDGL 02-26-2025
  • TKR 02-05-2025
  • Dividend Yield
  • MDGL N/A
  • TKR 1.77%
  • EPS Growth
  • MDGL N/A
  • TKR N/A
  • EPS
  • MDGL N/A
  • TKR 4.81
  • Revenue
  • MDGL $76,813,000.00
  • TKR $4,590,600,000.00
  • Revenue This Year
  • MDGL N/A
  • TKR N/A
  • Revenue Next Year
  • MDGL $195.95
  • TKR $2.67
  • P/E Ratio
  • MDGL N/A
  • TKR $15.95
  • Revenue Growth
  • MDGL N/A
  • TKR N/A
  • 52 Week Low
  • MDGL $168.25
  • TKR $69.35
  • 52 Week High
  • MDGL $368.29
  • TKR $94.71
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 61.81
  • TKR 57.37
  • Support Level
  • MDGL $266.44
  • TKR $75.94
  • Resistance Level
  • MDGL $343.97
  • TKR $78.84
  • Average True Range (ATR)
  • MDGL 20.88
  • TKR 1.87
  • MACD
  • MDGL 2.00
  • TKR 0.59
  • Stochastic Oscillator
  • MDGL 92.59
  • TKR 77.56

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.

About TKR Timken Company (The)

The Timken Company is a manufacturer of bearings, gear belts, industrial motion products and chain-related products. The company sells its portfolio of bearings, including tapered, spherical and cylindrical roller bearings, and thrust and ball bearings, through a network of authorized dealers to end users or directly to original equipment manufacturers. End-market sectors include general industrial, automotive, rail, energy, heavy truck, defense, agriculture, metals, mining, civil aerospace, construction, pulp and paper, and cement industries. Its segments are Engineered Bearings and Industrial Motion. Timken generates majority of its revenue in the United States of America.

Share on Social Networks: